IMMUNODOT RUBELLA TEST— 510(k) K885082

Name: FDA 510(k) clearance K885082
Creator: U.S. Food and Drug Administration
Published: 1989-02-02

Substantially Equivalent

General Biometrics, Inc.

FDA 510(k) clearance K885082 for IMMUNODOT RUBELLA TEST, Substantially Equivalent on 1989-02-02. Applicant: General Biometrics, Inc.. Device class: 2.

Clearance details

Applicant: General Biometrics, Inc.
Product code: Code LFX
Device class: Class 2
Regulation: 21 CFR 866.3510
Advisory panel: Microbiology
Date received: 1988-12-09
Decision date: 1989-02-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LFX

view all

K250588 — Access Rubella IgG2025-11-17
K243168 — Alinity i Rubella IgG2025-06-20
K122397 — LIAISON RUBELLA IGM, LIAISON CONTROL RUBELLA IGM2012-09-06
K093101 — MAGO 4S2011-01-21
K092587 — BIOPLEX 2200 RUBELLA & CMV IGM KIT ON THE BIOPLEX 2200 MULTI ANALYTE DETECTION SYSTEM2010-12-03

More clearances from General Biometrics, Inc.

view all

K924843 — IMMUNODOT(R) ENA/DNA AUTOIMMUNITY SCREENING PANEL1992-12-01
K920400 — IMMUNOWELL CARDIOLIPIN ANTIBODY (IGG) TEST1992-08-20
K920401 — IMMUNOWELL CARDIOLIPIN ANTIBODY (IGM) TEST1992-08-20
K911627 — IMMUNODOT BORRELIA (LYME) TEST1992-04-08
K911599 — IMMUNOWELL LYME (P39 RECOMBINANT) TEST1991-12-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.